Phase I and pharmacokinetic study of HGS-ETR2, a human monoclonal antibody to TRAIL R2, in patients with advanced solid malignancies

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 3055-3055 ◽  
Author(s):  
S. Pacey ◽  
R. E. Plummer ◽  
G. Attard ◽  
C. Bale ◽  
A. H. Calvert ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Pharmacokinetic Study ◽  
Human Monoclonal Antibody ◽  
Solid Malignancies

Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies

Oncology ◽  
2015 ◽  
Vol 90 (1) ◽  
pp. 10-20 ◽  
Author(s):  
Rastislav Bahleda ◽  
Jackie Baker ◽  
Christophe Massard ◽  
Sirish M. Gadgeel ◽  
Jane E. Rogers ◽  
...  
Keyword(s):  
Phase I ◽  
Pharmacokinetic Study ◽  
Dose Escalation ◽  
Solid Malignancies

CNTO 95, a fully human monoclonal antibody to alpha-v integrins: results of a phase I/II study in patients with metastatic melanoma

2006 ◽  
Vol 16 (Supplement 1) ◽  
pp. S39-S40 ◽  
Author(s):  
S. O??Day ◽  
J. Richards ◽  
R. Corringham ◽  
R. Beckman ◽  
Z. Lang ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
Metastatic Melanoma ◽  
Human Monoclonal Antibody

Phase 1 clinical trial of anti-CTLA4 human monoclonal antibody CP-675,206 in patients (pts) with advanced solid malignancies

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 2505-2505 ◽  
Author(s):  
L. H. Camacho ◽  
A. Ribas ◽  
J. A. Glaspy ◽  
G. Lopez-Berestein ◽  
J. M. Reuben ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Monoclonal Antibody ◽  
Phase 1 ◽  
Human Monoclonal Antibody ◽  
Phase 1 Clinical Trial ◽  
Solid Malignancies
Sign in / Sign up

Export Citation Format

Share Document